Indian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and Torrent Pharma are identified as potential market leaders. Despite initial stockouts online, companies are adjusting supply. The market for these diabetes and obesity drugs is expected to grow significantly in India.
Sebi warns listed firms, regulated entities against rising ‘Boss Scam’ cyber fraud
Sebi has issued a warning to all regulated entities regarding a rising cyber fraud known as the ‘Boss Scam’. In this scheme, fraudsters masquerade as